New drug offers promising treatment for pancreatic cancer patients
Scientists have invented a new drug which could improve life expectancy and quality for patients with hard-to-treat cancers, such as pancreatic cancer.
Honeybee venom found to kill agressive breast cancer cells
Researchers from the University of Western Australia have found that the venom of honeybees can destroy aggressive breast cancer cells in a lab setting.
Hearing loss in childhood cancer survivors linked to neurocognitive deficits
Scientists at St. Jude Children's Research Hospital have discovered that hearing loss in childhood cancer survivors is associated with an increased risk for neurocognitive deficits.
Oncology: Imaging biomarkers and the Alberta Radiopharmaceutical Collaboration
Dr Frank Wuest, Professor at Department of Oncology - University of Alberta, sheds light on the imaging biomarkers and the Alberta Radiopharmaceutical Collaboration in this special oncology focus.
Cancer research analysis: A focus on innovation
Here, the International Agency for Research on Cancer and other experts provide an in-depth analysis of cancer, the second leading cause of death after cardiovascular diseases plus the role of technology and innovation in the field.
Elucidating the pathogenesis of paediatric cancers
Prof Nicolo Riggi and Prof Ivan Stamenkovic from the University of Lausanne share their thoughts on the pathogenesis of paediatric cancers.
Cancer in Dogs and Humans: How is it alike and how is it different?
Here, Jaime F. Modiano examines the similarities of cancer in dogs and humans, exploring the idea of a common origin.
Reducing the burden of colorectal cancer across Europe
Monique van Leerdam, leading colorectal cancer expert and Member of the United European Gastroenterology Public Affairs Committee, discusses what action can be taken to reduce the heavy burden of colorectal cancer across Europe.
Enabling a global learning health system through genomic standards
Peter Goodhand and Angela Page from Global Alliance for Genomics and Health, explain their thoughts on enabling a global learning health system through genomic standards.
Advancements in Canada’s cancer care require strong government action
Here, Andrea Seale CEO of the Canadian Cancer Society, discusses the recently elected government’s commitments to support Canadians with cancer.
Should whole body MRI become first line in cancer staging?
Here, Professor Stuart Taylor at University College London (UCL), discusses the possibilities of whole body MRI in cancer staging.
UK cancer funding reaches £700 million for first time
The National Cancer Research Institute (NCRI) released figures today (4 February) showing that NCRI funding has reached £700 million for the first time.
Researchers create world’s most detailed map of breast cancer risk
An international team identified over 350 DNA 'errors' that increase risk of developing the disease, creating a map of breast cancer risk.
The Oral Health Foundation launches national mouth cancer campaign
More than 130 people joined The Oral Health Foundation yesterday, at the Houses of Parliament, as the charity announced this year's Mouth Cancer Action Month.
78 NHS trusts to receive new cancer screening machines
The 78 trusts, that have now been announced, will receive funding for new machines that will improve patient experience and lead to earlier cancer diagnosis.
New test could diagnose ovarian cancer up to two years earlier
A new test developed at Queen's University could allow ovarian cancer to be diagnosed at a stage up to two years earlier than current methods.
NHS to prioritise early cancer detection and survival
Cancer diagnosis will be made faster and more accurate with new technology to improve detection and survival, Matt Hancock announces.
Men’s Health Week: Raising awareness about male breast cancer
During Men’s Health Week (10-16 June 2019) Breast Cancer Haven aims to raise awareness of breast cancer amongst the male population and remind the public that the charity’s services are available to anyone affected by the disease.
The emotional impact of false positive cancer diagnosis
False positives in cancer diagnosis cost NHS millions each year and cause huge anxiety across the nation, Wesley Baker, CEO of ANCON Medical discusses the impact of outdated cancer diagnosis.
Urine test could replace smear test for cervical cancer
University of Manchester scientists latest research finds that urine testing may be as good as the smear test for preventing cervical cancer.
